Central regulation of blood pressure by the mineralocorticoid receptor
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Addition of mineralocorticoid receptor (MR) antagonists to standard therapy for heart failure, kidney disease, metabolic syndrome, and diabetes is increasing steadily in response to clinical trials demonstrating clear benefits. In addition to blocking deleterious activity of MR within the heart, vessels and kidneys, MR antagonists target MR in hemodynamic regulatory centers in the brain, thereby decreasing excessive sympathetic nervous system drive, vasopressin release, abnormal baroreceptor function, and circulating and tissue pro-inflammatory cytokines. However, brain MR are also involved with cognition, memory, affect and functions yet to be determined. Understanding specific central mechanisms involved in blood pressure regulation by MR is necessary for the development of agents to target downstream events specific to central hemodynamic regulation, not only to avoid the hypokalemia caused by inhibition of renal tubular MR, but also to avoid untoward long term effects of inhibiting brain MR that are not involved in blood pressure control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy
Geller, D. S., Farhi, A., Pinkerton, N., Fradley, M., Moritz, M., Spitzer, A., Meinke, G., Tsai, F. T. F., Sigler, P. B., & Lifton, R. P. (2000) · Science · doi:10.1126/science.289.5476.119 · Cited by 675
Hormones and the Stressed Brain
DE KLOET, E. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.001 · Cited by 314
Circumventricular Organs: Definition and Role in the Regulation of Endocrine and Autonomic Function
Ganong, W. F. (2000) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2000.03259.x · Cited by 307 · cited 1×
“Changes in osmotic pressure and concentrations of sodium, hormones and cytokines in the blood and cerebrospinal fluid are detected in the organum vasculosum lamina terminalis, subfornical organ and area postrema, circumventricular organs outside the blood brain barrier [72].”
BackgroundParaventricular hypothalamic nucleus: Axonal projections to the brainstem
Geerling, J. C., Shin, J., Chimenti, P. C., & Loewy, A. D. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22283 · Cited by 273 · cited 14×
“For example, the distinct anatomical distribution in the brain of different splice variants of Steroid Receptor Co-activator 1 (SRC-1) may be responsible for the opposite effect of stress levels of corticosterone on the release of corticotrophin releasing hormone from neurons of the paraventricular neuron (PVN) and ce…”
BackgroundInfluentialMultiple aspects of mineralocorticoid selectivity
Farman, N., & Rafestin-Oblin, M.-E. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.2.f181 · Cited by 268 · cited 1×
“The MR:aldosterone complex appears to be more stable and have higher transcription efficiency than MR:cortisol [8–10].”
Background11β-Hydroxysteroid dehydrogenases and the brain: From zero to hero, a decade of progress
Wyrwoll, C. S., Holmes, M. C., & Seckl, J. R. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.12.001 · Cited by 244
Meijer, O. C., Steenbergen, P. J., & de Kloet, E. R. (2000) · Endocrinology · doi:10.1210/endo.141.6.7489 · Cited by 200 · cited 1×
“For example, the distinct anatomical distribution in the brain of different splice variants of Steroid Receptor Co-activator 1 (SRC-1) may be responsible for the opposite effect of stress levels of corticosterone on the release of corticotrophin releasing hormone from neurons of the paraventricular neuron (PVN) and ce…”
BackgroundDesoxy‐cortico‐steron (21‐Oxy‐progesteron) aus Δ5‐3‐Oxy‐ätio‐cholensäure
Steiger, M., & Reichstein, T. (1937) · Helvetica Chimica Acta · doi:10.1002/hlca.193702001158 · Cited by 176
Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism.
Miyajima, E., Yamada, Y., Yoshida, Y., Matsukawa, T., Shionoiri, H., Tochikubo, O., & Ishii, M. (1991) · Hypertension · doi:10.1161/01.hyp.17.6.1057 · Cited by 163
Hitomi, H., Kiyomoto, H., Nishiyama, A., Hara, T., Moriwaki, K., Kaifu, K., Ihara, G., Fujita, Y., Ugawa, T., & Kohno, M. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.093955 · Cited by 140
Cited by
Keller, J., Gomez, R., Williams, G., Lembke, A., Lazzeroni, L., Murphy, G. M., & Schatzberg, A. F. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.120 · Cited by 922
“Since MR is densely distributed in the hippocampal region (26) and involved in hemodynamic centers in brain (27), it may be involved in the progression of AD inresponse to stressful stimuli (28).”
BackgroundBakris, G. L., Agarwal, R., Chan, J. C., Cooper, M. E., Gansevoort, R. T., Haller, H., Remuzzi, G., Rossing, P., Schmieder, R. E., Nowack, C., et al. (2015) · JAMA · doi:10.1001/jama.2015.10081 · Cited by 708
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
Agarwal, R., Kolkhof, P., Bakris, G., Bauersachs, J., Haller, H., Wada, T., & Zannad, F. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa736 · Cited by 638
The multifaceted mineralocorticoid receptor
Gomez‐Sanchez, E., & Gomez‐Sanchez, C. E. (2014) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2014.tb00569.x · Cited by 55
Metadata
- Authors
- Gomez-Sanchez, E. P., & Gomez-Sanchez, C. E.
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 350
- Issue
- 2
- Pages
- 289-298
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W2088988299
- Cited by
- 58
- References
- 14
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.